RxDoctor Payments Data

Carey Marder

Cardiovascular Disease · Vienna, VANPI 1205838471

Payments from drug & device makers

$2,157in general payments, 2019–2025

Across 112 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$337
  • Novartis$273
  • Johnson & Johnson$221
  • Amgen$210
  • AstraZeneca$209
  • Sanofi-aventis U.S. LLC$155
  • plus $752 from 13 others

What the payments were for

  • Food & beverage$2,150100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,157 in reported general payments places this provider in the 55th percentile of 548 cardiovascular disease providers in Virginia.

See all cardiovascular disease providers in Virginia

Other cardiovascular disease in Vienna

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →